These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25238391)

  • 41. Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease.
    Ghione I; Di Fonzo A; Saladino F; Del Bo R; Bresolin N; Comi GP; Rango M
    Neurotoxicology; 2007 May; 28(3):698-701. PubMed ID: 17335904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.
    Myhre R; Steinkjer S; Stormyr A; Nilsen GL; Abu Zayyad H; Horany K; Nusier MK; Klungland H
    BMC Neurol; 2008 Dec; 8():47. PubMed ID: 19087301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
    Gao L; Gómez-Garre P; Díaz-Corrales FJ; Carrillo F; Carballo M; Palomino A; Díaz-Martín J; Mejías R; Vime PJ; López-Barneo J; Mir P
    Eur J Neurol; 2009 Aug; 16(8):957-60. PubMed ID: 19473361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations.
    Hedrich K; Marder K; Harris J; Kann M; Lynch T; Meija-Santana H; Pramstaller PP; Schwinger E; Bressman SB; Fahn S; Klein C
    Neurology; 2002 Apr; 58(8):1239-46. PubMed ID: 11971093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.
    Pankratz N; Kissell DK; Pauciulo MW; Halter CA; Rudolph A; Pfeiffer RF; Marder KS; Foroud T; Nichols WC;
    Neurology; 2009 Jul; 73(4):279-86. PubMed ID: 19636047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease.
    Macedo MG; Verbaan D; Fang Y; van Rooden SM; Visser M; Anar B; Uras A; Groen JL; Rizzu P; van Hilten JJ; Heutink P
    Mov Disord; 2009 Jan; 24(2):196-203. PubMed ID: 18973254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Second mutation in PARK2 is absent in patients with sporadic Parkinson's disease and heterozygous exonic deletions/duplications in parkin gene.
    Shulskaya MV; Shadrina MI; Fedotova EY; Abramycheva NY; Limborska SA; Illarioshkin SN; Slominsky PA
    Int J Neurosci; 2017 Sep; 127(9):781-784. PubMed ID: 27798970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parkin mutations in familial and sporadic Parkinson's disease among Indians.
    Chaudhary S; Behari M; Dihana M; Swaminath PV; Govindappa ST; Jayaram S; Goyal V; Maitra A; Muthane UB; Juyal RC; Thelma BK
    Parkinsonism Relat Disord; 2006 May; 12(4):239-45. PubMed ID: 16500134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A consanguineous Turkish family with early-onset Parkinson's disease and an exon 4 parkin deletion.
    Dogu O; Johnson J; Hernandez D; Hanson M; Hardy J; Apaydin H; Özekmekçi S; Sevim S; Gwinn-Hardy K; Singleton A
    Mov Disord; 2004 Jul; 19(7):812-816. PubMed ID: 15254940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
    Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
    Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel compound heterozygous of PARKIN causes early-onset Parkinson's disease.
    Yu LH; Peng GP; Yuan Y; Liu XY; Ji F; Li Y; He FP; Luo BY; Ke Q
    Neurosci Lett; 2021 Jan; 744():135597. PubMed ID: 33373675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic mutations in early-onset Parkinson's disease Mexican patients: molecular testing implications.
    Monroy-Jaramillo N; Guerrero-Camacho JL; Rodríguez-Violante M; Boll-Woehrlen MC; Yescas-Gómez P; Alonso-Vilatela ME; López-López M
    Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):235-44. PubMed ID: 24677602
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mitochondrial impairment observed in fibroblasts from South African Parkinson's disease patients with parkin mutations.
    van der Merwe C; Loos B; Swart C; Kinnear C; Henning F; van der Merwe L; Pillay K; Muller N; Zaharie D; Engelbrecht L; Carr J; Bardien S
    Biochem Biophys Res Commun; 2014 May; 447(2):334-40. PubMed ID: 24721425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patients.
    Djarmati A; Hedrich K; Svetel M; Schäfer N; Juric V; Vukosavic S; Hering R; Riess O; Romac S; Klein C; Kostic V
    Hum Mutat; 2004 May; 23(5):525. PubMed ID: 15108293
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distribution, type, and origin of Parkin mutations: review and case studies.
    Hedrich K; Eskelson C; Wilmot B; Marder K; Harris J; Garrels J; Meija-Santana H; Vieregge P; Jacobs H; Bressman SB; Lang AE; Kann M; Abbruzzese G; Martinelli P; Schwinger E; Ozelius LJ; Pramstaller PP; Klein C; Kramer P
    Mov Disord; 2004 Oct; 19(10):1146-57. PubMed ID: 15390068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Defining the ends of Parkin exon 4 deletions in two different families with Parkinson's disease.
    Clarimon J; Johnson J; Dogu O; Horta W; Khan N; Lees AJ; Hardy J; Singleton A
    Am J Med Genet B Neuropsychiatr Genet; 2005 Feb; 133B(1):120-3. PubMed ID: 15635662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.
    Chien HF; Rohé CF; Costa MD; Breedveld GJ; Oostra BA; Barbosa ER; Bonifati V
    Neurogenetics; 2006 Mar; 7(1):13-9. PubMed ID: 16328510
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular pathogenesis of Parkinson's disease: identification of mutations in the Parkin gene in Indian patients.
    Biswas A; Gupta A; Naiya T; Das G; Neogi R; Datta S; Mukherjee S; Das SK; Ray K; Ray J
    Parkinsonism Relat Disord; 2006 Oct; 12(7):420-6. PubMed ID: 16793319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Parkinson's disease in Ireland: clinical presentation and genetic heterogeneity in patients with parkin mutations.
    Wiley J; Lynch T; Lincoln S; Skipper L; Hulihan M; Gosal D; Bisceglio G; Kachergus J; Hardy J; Farrer MJ
    Mov Disord; 2004 Jun; 19(6):677-81. PubMed ID: 15197707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.